CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF
Learn how Inotiv’s proteomics services are helping researchers gain deeper insights into drug target systems, to better select disease models, and quantify pathology data
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists
As part of our aim to improve our service to scientists and laboratory professionals, we invite you to complete the SelectScience 2025 survey
As the FDA and NIH plan to phase out animal-based drug testing, organ-chip models are filling this critical gap
The comprehensive preclinical screening platform was validated using HER2 x TROP2 bsADC as a proof of concept
To help simulate exact environmental conditions for shipping, storage, or research environments, offering repeatable and consistent performance
Designed to support drug developers in bringing their therapeutics to market faster, more efficiently, and with greater reliability
With smarter tools, AI-powered insights, and a focus on user experience, lab automation is becoming more accessible, flexible, and impactful than ever
With intuitive workflows, quick setup, and expert support, Veya is making automation accessible and cost-effective for first-time users
This guest editorial outlines how the collaboration between Camena Bioscience and SPT Labtech is driving innovation in the field of DNA synthesis Discover how Camena Bioscience is using its gSynth® platform and SPT Labtech automated liquid handling to overcome DNA synthesis bottlenecks and accelerate applications in CRISPR screening and drug discovery
Guest editorial features key takeaways from Balancing the Future Podcast, by METTLER TOLEDO
Experienced clinical immunologist and global life science executive to support progression of lead candidate through the clinic
New UK-based technical innovation facility opens in Nuneaton on MIRA Tech Park
A nasal vaccine could prove both more effective medically and more tolerable for young children and adults who may fear needles
New workflow streamlines protein structural analysis and supports the growing role of AI in drug discovery
Breakthrough demonstrates the potential of 3D multi-omics to revolutionize drug discovery timelines and success rates across various disease area
Advance gene therapy precision by reliably testing pre-existing AAV immunogenicity
A renewed image for a company in constant evolution, driven by curiosity
Strategic collaboration to innovate Treg and TIL therapies, streamline cell therapy workflows, and enhance manufacturing efficiency
Scalable single-molecule analysis could uncover low-abundance proteins and proteoforms critical for understanding complicated disease networks and therapeutic responses
Scientists from the University of Edinburgh’s Wallace Lab revel a new discovery that a common bacterium can turn everyday plastic waste into the painkiller
New research shows integrated services can reduce Phase I-III study times by up to nearly three years, generating strong ROI for biotech and biopharma customers
